CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN) [A Test In Focus]
The new CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN) assay is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test should be ordered on patients with clinical suspicion of essential thrombocythemia or primary myelofibrosis. View this post for details and a video overview by Dr. Rong He.
![]() |
|
|
|
![]() |
Submit only 1 of the following specimens:
|
![]() |
When should I order this test?This test should be ordered on patients with clinical suspicion of essential thrombocythemia or primary myelofibrosis. It is especially helpful in cases with ambiguous etiology of thrombocytosis, equivocal bone marrow morphologic findings of MPN, and unexplained reticulin fibrosis. The assay is also useful for prognostication of primary myelofibrosis and thrombotic risk assessment in essential thrombocythemia. Key points:
|
![]() |
|
|
|